Patients with T1DM often exhibit more severe PD than non−diabetic individuals, characterized by elevated systemic levels of pro-inflammatory cytokines such as IL−1β, IL−6 and TNFα. This evidence concerns the gene IL1B and type 1 diabetes mellitus.